KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,319,917 | -19.5% | 7,806 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $1,640,484 | +74.4% | 7,565 | +46.1% | 0.00% | +100.0% |
| Q1 2023 | $940,529 | +21.0% | 5,178 | +30.9% | 0.00% | 0.0% |
| Q4 2022 | $777,585 | +16.6% | 3,957 | +33.4% | 0.00% | 0.0% |
| Q3 2022 | $667,000 | +75.5% | 2,966 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $380,000 | -7.8% | 3,003 | -7.5% | 0.00% | 0.0% |
| Q1 2022 | $412,000 | -20.3% | 3,246 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $517,000 | +18.3% | 3,946 | +10.5% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | +7.4% | 3,571 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $407,000 | -5.1% | 3,571 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $429,000 | +99.5% | 3,571 | +68.8% | 0.00% | – |
| Q4 2020 | $215,000 | -39.9% | 2,116 | -54.3% | 0.00% | -100.0% |
| Q3 2020 | $358,000 | -46.1% | 4,631 | -22.2% | 0.00% | -50.0% |
| Q2 2020 | $664,000 | +52.6% | 5,951 | -1.7% | 0.00% | +100.0% |
| Q1 2020 | $435,000 | – | 6,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |